SLC7A11 and hepatocellular carcinoma: And our data further revealed the pronounced upregulation of SLC7A11 in human HCC tissues, whereas HED treatment significantly downregulated its expression, suggesting that SLC7A11 might be a principal molecular target of HED in SOR-mediated ferroptosis.